Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

October 31, 2013

Conditions
Diarrhea
Interventions
DRUG

Elsiglutide

24 mg administered s.c. once daily for 4 consecutive days from Day 1 chemotherapy

DRUG

Placebo

24 mg administered s.c. once daily for 4 consecutive days from Day 1 chemotherapy

Trial Locations (21)

1233

Department of Chemotherapy Specialized Hospital for Active Treatment of Oncological Diseases, Sofia

1784

Department of Chemotherapy Specialized Hospital for Active Treatment of Oncological Diseases, Sofia

7002

Department of Chemotherapy, Complex Oncology Center, Rousse

9010

"Oncology Clinic, Multiprofile Hospital for Active Treatment Sveta Marina", Varna

9024

Petz Aladar County Teaching Hospital, Center of Oncologic Radiology Hungary, Győr

9700

Chemotherapy Department, Complex Oncology Center, Shumen

150054

Regional Oncology Hospital, Yaroslavl

163045

Regional Oncology Center, Arkhangelsk

197110

City #9 Hospital, Saint Petersburg

198255

City Clinical Oncology Center, Saint Petersburg

305035

Kursk Regional Clinical Oncology Center, Kursk

357502

Pyatigorsk Oncology Center, Pyatigorsk

400015

Prof. Dr. Ion Chiricuta Institute of Oncology, Medical Oncology Department, Cluj-Napoca

430031

Dr. Constantin Opris Clinical Country Emergency Hospital Baia Mare, Department of Oncology, Baia Mare

432063

Regional Clinical Oncology Center - Chemotherapy Department, Ulyanovsk

700106

Euroclinic Oncology Center SRL - Medical Oncology Department, Iași

720237

Sf. Ioan cel Nou Emergency Clincal County Hospital, Suceava

H-1082

Semmelweis University, Department of Diagnostic Radiology and Oncotherapy, Budapest

H-4043

Kenezy Hospital, Department of Clinical Pharmacology, Infectology and Allergology, Debrecen

H-6720

Szeged Medical University Department of Oncology and Oncotherapy, Szeged

022328

Fundeni Clinical Institute - Medical Oncology Department, Bucharest

Sponsors
All Listed Sponsors
lead

Helsinn Healthcare SA

INDUSTRY